Webinar
10
Nov
2025
2025
18
00
CET
CET
The urgency to treat with the best treatment options in the first-line MBC setting
This webinar will focus on first-line treatment strategies for metastatic breast cancer (MBC), covering key subtypes from triple-negative to HR+/HER2-. Experts will discuss aggressiveness, risk assessment, and personalised approaches, combining presentations with interactive Q&A to address practical considerations in clinical practice.
Speakers

Expert
Evandro de Azambuja
Université Libre de Bruxelles (U.L.B), Hôpital Universitaire de Bruxelles and Institut Jules Bordet, Brussels, Belgium

Expert
Esther Sanfeliu
Biomedical Diagnostic Centre (CDB), Hospital Clínic de Barcelona, Barcelona, Spain